CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Operating activities
Net loss	$ (3,139,723)	$ (9,218,081)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	2,213	3,338
Equity-based compensation expense	162,676	326,804
Changes in operating assets and liabilities:
Grants receivable	0	1,480,490
Prepaid expenses and other assets	403,401	546,681
Accounts payable	16,613	(671,506)
Accrued expenses and other current liabilities	128,673	(53,608)
Net cash used in operating activities	(2,426,147)	(7,585,882)
Financing activities
Proceeds from issuance of equity securities, net	88,703	7,020,890
Payments on note payable	(289,643)	0
Net cash (used in) provided by financing activities	(200,940)	7,020,890
Net decrease in cash, cash equivalents and restricted cash	(2,627,087)	(564,992)
Cash, cash equivalents and restricted cash at beginning of period	5,899,910	12,106,435
Cash, cash equivalents and restricted cash at end of period	3,272,823	11,541,443
Non-cash investing and financing activities:
Cash paid for interest	4,816	0
Accrued issuance costs for issuance of equity securities	$ 23,585	$ 100,419